BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 237 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,963 | -33.6% | 724 | -6.3% | 0.00% | – |
| Q1 2024 | $25,540 | +44.1% | 773 | +18.7% | 0.00% | – |
| Q4 2023 | $17,720 | -77.8% | 651 | -80.3% | 0.00% | -100.0% |
| Q3 2023 | $79,654 | +28.1% | 3,312 | +70.0% | 0.00% | – |
| Q2 2023 | $62,200 | +115085.2% | 1,948 | +11.0% | 0.00% | – |
| Q1 2023 | $54 | -20.6% | 1,755 | +0.8% | 0.00% | -100.0% |
| Q4 2022 | $68 | -99.9% | 1,741 | +19.7% | 0.00% | 0.0% |
| Q3 2022 | $64,000 | +48.8% | 1,454 | +31.0% | 0.00% | – |
| Q2 2022 | $43,000 | -46.2% | 1,110 | -20.1% | 0.00% | -100.0% |
| Q1 2022 | $80,000 | -23.8% | 1,390 | -7.9% | 0.00% | 0.0% |
| Q4 2021 | $105,000 | -81.7% | 1,510 | -77.1% | 0.00% | -66.7% |
| Q3 2021 | $574,000 | +147.4% | 6,600 | +266.7% | 0.00% | +200.0% |
| Q2 2021 | $232,000 | +61.1% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $144,000 | -2.0% | 1,800 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $147,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |